Excelra partners with XtalPi

By The Science Advisory Board staff writers

January 21, 2022 -- Excelra has partnered its Global Online Structure Activity Relationship Database (Gostar) with XtalPi, an artificial intelligence-based pharmaceutical biotechnology company, to reinvent the industry's approach to drug R&D.

Excelra will provide absorption, distribution, metabolism, excretion, and toxicity (ADMET) datasets in the Gostar database to XtalPi. Gostar's ADMET data will power XtalPi's predictive models. The data will help XtalPi with high precision and predictability to address clinical failures of new chemical entities, the companies said.

The ADMET datasets of Gostar are built with a proprietary quality management system-International Organization for Standardization-certified curation process that is powered by natural language processing and human intelligence.

Gostar provides information encompassing over eight million compounds, which is manually curated from a variety of sources, including patents and journal articles. The database contains over 29 million structure activity relationship-associated data points that can be used for applications across various stages of drug discovery and development as well as target validation, hit identification, early lead identification, and optimization.

No financial details of the collaboration were disclosed.

Copyright © 2022 scienceboard.net

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.